These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1036842

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The fibrinolytic response to ancrod therapy: characterization of fibrinogen and fibrin degradation products.
    Prentice CR, Hampton KK, Grant PJ, Nelson SR, Nieuwenhuizen W, Gaffney PJ.
    Br J Haematol; 1993 Feb; 83(2):276-81. PubMed ID: 8457476
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of ancrod and heparin as anticoagulants following endarterectomy in the dog.
    Daniel TM, Pizzo SV, Mckee PA.
    Ann Surg; 1976 Aug; 184(2):223-8. PubMed ID: 952568
    [Abstract] [Full Text] [Related]

  • 7. The effects of ancrod, the coagulating enzyme from the venom of Malayan pit viper (A. rhodostoma) on prothrombin and fibrinogen metabolism and fibrinopeptide A release in man.
    Bell WR, Shapiro SS, Martinez J, Nossel HL.
    J Lab Clin Med; 1978 Apr; 91(4):592-604. PubMed ID: 641385
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of thromboxane synthetase inhibition on platelet function and morphology during ovine pregnancy-induced hypertension.
    Miller KW, Keith JC.
    Thromb Haemost; 1988 Dec 22; 60(3):365-71. PubMed ID: 3238644
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative study of blood clotting factors in anaphylactic and primary and secondary endotoxin shock.
    Ferrell WJ, Jabs CM, Robb HJ, Mammen EF.
    Ann Clin Lab Sci; 1983 Dec 22; 13(4):291-8. PubMed ID: 6194736
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of arterial thrombus formation in two canine models: comparison of ancrod, a fibrinogen-depleting agent, the thrombin-inhibitor r-hirudin, and the glycoprotein 11b/IIIa-receptor antagonist Ro 43-8857.
    Rübsamen K, Hornberger W, Kirchengast M.
    Thromb Haemost; 1995 Nov 22; 74(5):1353-60. PubMed ID: 8607122
    [Abstract] [Full Text] [Related]

  • 16. Anticoagulation by ancrod for carbon dioxide removal by extracorporeal membrane lung in the dog.
    Sinclair ME, Reber G, Schweizer A, Dorrington KL, De Moerloose P, Bouvier CA, Gardaz JP.
    J Thorac Cardiovasc Surg; 1989 Feb 22; 97(2):275-81. PubMed ID: 2492625
    [Abstract] [Full Text] [Related]

  • 17. Fibrin formation and proteolysis during ancrod treatment. Evidence for des-A-profibrin formation and thrombin independent factor XIII activity.
    Dempfle CE, Argiriou S, Alesci S, Kucher K, Müller-Peltzer H, Rübsamen K, Heene DL.
    Ann N Y Acad Sci; 2001 Feb 22; 936():210-4. PubMed ID: 11460476
    [Abstract] [Full Text] [Related]

  • 18. [Correlation between products of fibrin degradation and platelet dysfunction in chronic renal failure. Effects of aspirin].
    Lazzari MA, Pavlovsky M, Martínez Canaveri A.
    Medicina (B Aires); 1977 Feb 22; 37(2):97-105. PubMed ID: 895494
    [No Abstract] [Full Text] [Related]

  • 19. Inhibitory effect of staphylokinase on platelet aggregation.
    Suehiro A, Oura Y, Ueda M, Kakishita E.
    Thromb Haemost; 1993 Nov 15; 70(5):834-7. PubMed ID: 7510426
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.